期刊文献+

19例21羟化酶缺陷症临床分析 被引量:5

Clinical Analysis of 19 Patients with 21 Hydroxylase Deficiency
暂未订购
导出
摘要 目的分析19例21羟化酶缺陷症(21OHD)患者的临床和随访资料,提高该病的诊断和治疗水平。方法全面收集患者临床、基础激素测定、影像学以及规律治疗和随访的资料,对比治疗前后临床症状和各项检测指标的改变。结果所有患者临床表现均为单纯男性化型。其中男性患者(n=3)表现为第二性征发育提前出现,平均出现年龄(9.3±2.8)岁,阴茎异常增大;女性患者(n=16)“原发性闭经”占87.5%,阴蒂肥大,并存在不同程度的阴唇融合。17羟孕酮(17OHP)平均水平达(63.42±35.07)μg/L,促肾上腺激素、去氢表雄酮和睾酮水平均明显升高。肾上腺CT增强扫描发现双侧肾上腺增生或腺瘤。经肾上腺皮质激素替代治疗后,患者临床症状均有改善。17OHP水平降至(3.15±2.71)μg/L(P<0.01),T、DHEAS和ACTH水平均显著下降(P<0.01)。结论单纯男性化型21OHD女性患者,原发性闭经仍是最常见主诉;而17OHP对于该型的诊断及疗效的观察均有重要意义。 Objective Clinical data of 19 Chinese patients with 21 hydroxylase deficiency (21OHD) were analyzed to improve the diagnosis and treatment level. Methods Clinical features and laboratory data were collected from 19 patients with 21OHD before and after treatment. Results In male patients, the average age of early appearance of secondary sexual character was (9.3± 2.8)yrs, and excess androgen resulted in phallic enlargement. Primary amenorrhea was the most common complaint in female(87.5% ), and the signs included a varying degree of labioscrotal fusion and clitoral enlargement. The average level of 17-hydroxy progesterone (17OHP) was (63.42± 35.07) p,g/L, and adrenocorticotrophic hormone ( ACTH), dehydroepiandrosterone (sodium) sulfate (DHEAS) and testosterone (T) were obviously elevated. CT scan showed bilateral adrenal hyperplasia. The level of 17OHP was significantly decreased after treatment[ (63.42± 35.07) μg/L vs (3.15± 2.71 )μg/L] (P 〈 0.01 ). T, DHEAS and ACTH were also de- creased significantly(P 〈0.01). Conclusion In female patients with simple virilizing form of 21OHD, primary amenorrhea was the most common complaint, and 17OHP is a good index to the diagnosis and prognosis of the disease.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2006年第1期10-12,共3页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市教委重点学科基金(E03007)资助项目
关键词 先天性肾上腺增生 21羟化酶缺陷症 17羟孕酮 congenital adrenal hyperplasia 21 hydroxylase deficiency 17-hydroxy progesterone
  • 相关文献

参考文献11

  • 1[1]Therrell BL.Newborn screening for congenital adrenal hyperplasia[J].Endocrinol Metab Clin North Am,2001,30(1):15-30.
  • 2[2]Merke DP,Bornstein SR.Congenital adrenal hyperplasia[J].Lancet,2005,365(9477):2125-2136.
  • 3芦惠,孙丽静.新生儿先天性肾上腺皮质增生症(附10例临床分析)[J].中国优生与遗传杂志,2000,8(2):96-96. 被引量:4
  • 4[5]Moran C,Azziz R,Carmina E,et al.21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder:a multicenter study[J].Am J Obstet Gynecol,2000,183(6):1468-1474.
  • 5[6]New MI,Lorenzen F,Lerner AJ,et al.Genotyping steroid 21- hydroxylase deficiency:hormonal reference data.[J].J Clin Endocrinol Metab,1983,57(2):320-326.
  • 6[7]Allen DB,Hoffman GL,Fitzpatrick P,et al.Improved precision of newborn screening for congenital adrenal hyperplasia using weight- adjusted criteria for 17 hydroxyprogesterone levels[J].J Pediatr,1997,130(1):128-133.
  • 7[8]Gruneiro-Papendieck L,Prieto L,Chiesa A,et al.Neonatal screening program for congenital adrenal hyperplasia:adjustments to the recall protocol[J].Horm Res,2001,55(6):271-277.
  • 8[9]Azziz R,Hincapie LA,Knochenhauer ES,et al.Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women:a prospective study[J].Fertil Steril,1999,72(5):915-925.
  • 9[10]Charmandari E,Hindmarsh PC,Johnston A et al.Congenital adrenal hyperplasia due to 21-hydroxylase deficiency:alterations in cortisol pharmacokinetics at puberty[J].J Clin Endocrinol Metab,2001,86(6):2701 2708.
  • 10[11]Rivkees SA,Crawford JD.Dexamethasone treatment of virilizing congenital adrenal hyperplasia:the ability to achieve normal growth[J].Pediatrics,2000,106(4):767-773.

二级参考文献2

  • 1吴静怡 沈椎堂 等.健康与窒息新生儿血游离钙变化的观察[J].中华儿科杂志,1988,26(1):21-21.
  • 2Birdsey TJ, Husain SM, Carland Mo. The effect of diabetes mellitus on urinarycalcium excretion in pregnant rats and their offspring. J Endocrinol,1995,145(1):11-8

共引文献3

同被引文献89

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部